Thermo Fisher CEO Says AI Will Drive More Pharma Spending — Sees 7% Organic Growth By 2028
Thermo Fisher Scientific (TMO) CEO Marc Casper said artificial intelligence could ultimately increase spending across the pharmaceutical industry rather than reduce demand for laboratory research.In an interview with CNBC on Tuesday, Casper said AI is helping drugmakers identify ineffective drugs q…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.